BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population

Background: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. M...

Full description

Bibliographic Details
Main Authors: Ismail Yilmaz, Mehmet Gamsizkan, Zafer Kucukodaci, Ufuk Berber, Dilaver Demirel, Aptullah Haholu, Gizem Narli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=Yilmaz
id doaj-33d5bd522e37460cad88543d2e1015b6
record_format Article
spelling doaj-33d5bd522e37460cad88543d2e1015b62020-11-24T23:22:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292015-01-0158327928410.4103/0377-4929.162831BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish populationIsmail YilmazMehmet GamsizkanZafer KucukodaciUfuk BerberDilaver DemirelAptullah HaholuGizem NarliBackground: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. Materials and Methods: Forty-seven primary cutaneous melanomas were included in our study. Sanger sequencing method was used for mutation analysis in all cases. Results: Mean age was 62.1 (29-101) years. Female:male ratio was 17:30. Among 47 melanomas, 14 (29.8%) BRAF, 10 (21.3%) NRAS, 4 (8.5%) KIT and 1(2.1%) GNAQ gene mutations were detected. Two of the KIT mutations were found in acral lentiginous melanoma (ALM). In the head and neck region, mutation frequency was significantly lower than in other locations (P = 0.035). The only GNAQ gene mutation (p.Q209L) was detected in a melanoma arising from blue nevus located on the scalp. None of the melanomas harbored NRAS exon 2, KIT exon 13/17/18, GNAQ exon 4 and GNA11 exon 4/5 mutations. Overall mutation frequency did not show significant difference between metastatic (8/14, 57.1%) and nonmetastatic (18/33, 54.5%) patients. We did not observe any significant association between mutation status and gender or age of various patients. Conclusions: Our results support that BRAF and NRAS gene mutations are common in cutaneous melanomas. The activating mutations of KIT gene are rare and especially seen in ALM. GNAQ and GNA11 mutations are infrequent in cutaneous melanomas and may be associated only with melanomas arising from blue nevus.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=YilmazGene mutationmelanomamutation analysis
collection DOAJ
language English
format Article
sources DOAJ
author Ismail Yilmaz
Mehmet Gamsizkan
Zafer Kucukodaci
Ufuk Berber
Dilaver Demirel
Aptullah Haholu
Gizem Narli
spellingShingle Ismail Yilmaz
Mehmet Gamsizkan
Zafer Kucukodaci
Ufuk Berber
Dilaver Demirel
Aptullah Haholu
Gizem Narli
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
Indian Journal of Pathology and Microbiology
Gene mutation
melanoma
mutation analysis
author_facet Ismail Yilmaz
Mehmet Gamsizkan
Zafer Kucukodaci
Ufuk Berber
Dilaver Demirel
Aptullah Haholu
Gizem Narli
author_sort Ismail Yilmaz
title BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
title_short BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
title_full BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
title_fullStr BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
title_full_unstemmed BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
title_sort braf, kit, nras, gnaq and gna11 mutation analysis in cutaneous melanomas in turkish population
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2015-01-01
description Background: KIT and mitogen-activated protein kinase cascade are important for melanomagenesis. In the present study, we analyzed the frequency of BRAF, NRAS, KIT, GNAQ and GNA11 gene mutations and investigated their association with clinicopathological features of melanomas in Turkish population. Materials and Methods: Forty-seven primary cutaneous melanomas were included in our study. Sanger sequencing method was used for mutation analysis in all cases. Results: Mean age was 62.1 (29-101) years. Female:male ratio was 17:30. Among 47 melanomas, 14 (29.8%) BRAF, 10 (21.3%) NRAS, 4 (8.5%) KIT and 1(2.1%) GNAQ gene mutations were detected. Two of the KIT mutations were found in acral lentiginous melanoma (ALM). In the head and neck region, mutation frequency was significantly lower than in other locations (P = 0.035). The only GNAQ gene mutation (p.Q209L) was detected in a melanoma arising from blue nevus located on the scalp. None of the melanomas harbored NRAS exon 2, KIT exon 13/17/18, GNAQ exon 4 and GNA11 exon 4/5 mutations. Overall mutation frequency did not show significant difference between metastatic (8/14, 57.1%) and nonmetastatic (18/33, 54.5%) patients. We did not observe any significant association between mutation status and gender or age of various patients. Conclusions: Our results support that BRAF and NRAS gene mutations are common in cutaneous melanomas. The activating mutations of KIT gene are rare and especially seen in ALM. GNAQ and GNA11 mutations are infrequent in cutaneous melanomas and may be associated only with melanomas arising from blue nevus.
topic Gene mutation
melanoma
mutation analysis
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2015;volume=58;issue=3;spage=279;epage=284;aulast=Yilmaz
work_keys_str_mv AT ismailyilmaz brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT mehmetgamsizkan brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT zaferkucukodaci brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT ufukberber brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT dilaverdemirel brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT aptullahhaholu brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
AT gizemnarli brafkitnrasgnaqandgna11mutationanalysisincutaneousmelanomasinturkishpopulation
_version_ 1725567447892754432